Global Corporate Affairs Archives | Page 172 of 1086 | Be Korea-savvy

Archive by category Global Corporate Affairs

US Energy Dominance Faces Long-Term Challenges, Wood Mackenzie Report Finds

US Energy Dominance Faces Long-Term Challenges, Wood Mackenzie Report Finds

US Energy Dominance Faces Long-Term Challenges, Wood Mackenzie Report Finds US oil and gas production to plateau and decline between 2035-2040 LONDON / HOUSTON / SINGAPORE, 17 April 2025 (Korea Bizwire) –While the United States currently dominates global oil and gas production, it faces significant challenges to maintaining the same level of leadership in the coming decades, [...]

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

SAN DIEGO and BASEL, Switzerland , April 17, 2025 (Korea Bizwire) — Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced the appointment of John Schmid, a seasoned biotechnology executive, to its Board of Directors. “It is a pleasure to welcome John to our Board,” said [...]

Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors

Boehringer Ingelheim announces succession Chairmen Shareholders’ Committee and Board of Managing Directors

Christian Boehringer to hand over as Chairman of the Shareholders’ Committee to Hubertus von Baumbach  Shashank Deshpande, Member of the Board of Managing Directors, to succeed Hubertus von Baumbach as Chairman of the Board of Managing Directors  Appointments to be effective July 1, 2025  The Shareholders’ Committee of Boehringer Ingelheim have announced the following appointments in the Shareholders’ Committee and [...]

Pluxee continues to deliver solid business and financial performance in H1 and raises its Fiscal 2025 Recurring EBITDA margin objective

Pluxee continues to deliver solid business and financial performance in H1 and raises its Fiscal 2025 Recurring EBITDA margin objective

First Half Fiscal 2025 Results Issy-les-Moulineaux, France – April 17, 2025 Pluxee continues to deliver solid business and financial performance in H1 and raises its Fiscal 2025 Recurring EBITDA margin objective First Half Fiscal 2025 highlights Continued execution of the Group’s 3-year strategic growth plan, successfully advancing key initiatives, including M&A, while consistently driving sustainable and profitable growth Robust business dynamics [...]

Christie’s International Real Estate Enters New Zealand Through Partnership with Leading Brokerage Team on the Country’s North Island

Christie’s International Real Estate Enters New Zealand Through Partnership with Leading Brokerage Team on the Country’s North Island

Russell and Angela Thomas join the Christie’s International Real Estate network as the co-founders of Thomas Estates | Christie’s International Real Estate. The duo will open their inaugural office in Hamilton, to serve the greater Waikato region with plans to expand across the country. HAMILTON, New Zealand and CHICAGO, April 16, 2025 (Korea Bizwire) – [...]

CGTN: China, Malaysia join forces for high-level strategic community with shared future

CGTN: China, Malaysia join forces for high-level strategic community with shared future

CGTN published an article highlighting how visiting Chinese President Xi Jinping has drawn a new development blueprint for China-Malaysia ties for the next 50 years and how the two countries are jointly promoting a high-level strategic community with a shared future to bring more benefits to the two peoples and contribute to regional prosperity. BEIJING, [...]

Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease

Biosidus Announces Promising Interim Results from Phase III Study on Agalsidase Beta for Fabry Disease

BUENOS AIRES, Argentina, April 16, 2025 (Korea Bizwire) – Biosidus, an Argentinean pioneer company in biotechnology research, development, and the production of high-quality biosimilars, has announced encouraging interim results from the Phase III SMILE1 study. After 26 weeks of treatment, the study successfully met its primary endpoint, underscoring the potential of agalsidase beta as a safe and effective biosimilar treatment for Fabry [...]

WillScot to Announce First Quarter 2025 Results on May 1, 2025

WillScot to Announce First Quarter 2025 Results on May 1, 2025

PHOENIX, April 16, 2025 (Korea Bizwire) – WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions, today announced that it will release its first quarter 2025 financial results on May 1, 2025, after market close. The Company’s management team will host a conference call and webcast on May 1, [...]

Ascom Annual General Meeting approves all proposals of the Board of Directors

Ascom Annual General Meeting approves all proposals of the Board of Directors

Ad hoc announcement pursuant to Art. 53 LR Baar, Switzerland, April 16, 2025 At the Annual General Meeting held on April 16, 2025, in Zug, the shareholders of Ascom Holding AG approved by a large majority all proposals presented by the Board of Directors. 54 shareholders attended the Annual General Meeting. In total, 20’238’079 registered [...]

Sabin Begins Marburg Vaccine Trial in U.S

Sabin Begins Marburg Vaccine Trial in U.S

WASHINGTON, April 16, 2025 (Korea Bizwire) — The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and Uganda, with initial findings from that research expected [...]